FET Clinical Trials in Hangzhou, Zhejiang
6 recruitingHangzhou, Zhejiang, China
Showing 1–6 of 6 trials
Recruiting
Phase 1
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines392 enrolled47 locationsNCT06427941
Recruiting
Utility of Whole Genome Sequencing in Fetuses With Abnormal Ultrasound Findings
prenatal diagnosisFetal Diseases
Women's Hospital School Of Medicine Zhejiang University1,000 enrolled4 locationsNCT07606989
Recruiting
Phase 2
Efficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or Bevacizumab
Safety
Second Affiliated Hospital, School of Medicine, Zhejiang University40 enrolled2 locationsNCT07253896
Recruiting
The Safety and Efficiency of Endovascular Treatment of Acute or Subacute Thromboembolic Occlusions of Lower Extremity.
Efficacy, SelfSafety IssuesThromboembolic Disease+2 more
First People's Hospital of Hangzhou400 enrolled1 locationNCT04861506
Recruiting
Phase 2
Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer
Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer
Zhejiang Cancer Hospital20 enrolled1 locationNCT06562920
Recruiting
Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen
Breast CancerEfficacyLiposomal Doxorubicin+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University150 enrolled1 locationNCT05731258